229 related articles for article (PubMed ID: 24547943)
1. RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain.
Gao Y; Wang ZY; Zhang J; Zhang Y; Huo H; Wang T; Jiang T; Wang S
Biomacromolecules; 2014 Mar; 15(3):1010-8. PubMed ID: 24547943
[TBL] [Abstract][Full Text] [Related]
2. Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain.
Huo H; Gao Y; Wang Y; Zhang J; Wang ZY; Jiang T; Wang S
J Colloid Interface Sci; 2015 Jun; 447():8-15. PubMed ID: 25689522
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis.
Gooding M; Malhotra M; McCarthy DJ; Godinho BM; Cryan JF; Darcy R; O'Driscoll CM
Eur J Pharm Sci; 2015 Apr; 71():80-92. PubMed ID: 25703259
[TBL] [Abstract][Full Text] [Related]
4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
5. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse.
Liu Y; Li D; Liu Z; Zhou Y; Chu D; Li X; Jiang X; Hou D; Chen X; Chen Y; Yang Z; Jin L; Jiang W; Tian C; Zhou G; Zen K; Zhang J; Zhang Y; Li J; Zhang CY
Sci Rep; 2015 Dec; 5():17543. PubMed ID: 26633001
[TBL] [Abstract][Full Text] [Related]
6. Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy.
Rassu G; Soddu E; Posadino AM; Pintus G; Sarmento B; Giunchedi P; Gavini E
Colloids Surf B Biointerfaces; 2017 Apr; 152():296-301. PubMed ID: 28126681
[TBL] [Abstract][Full Text] [Related]
7. Transvascular delivery of small interfering RNA to the central nervous system.
Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N
Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664
[TBL] [Abstract][Full Text] [Related]
8. RVG peptide as transfection reagent for specific cdk4 gene silencing in vitro and in vivo.
Rohn S; Suttkus A; Arendt T; Ueberham U
J Drug Target; 2012 May; 20(4):381-8. PubMed ID: 22443811
[TBL] [Abstract][Full Text] [Related]
9. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
[TBL] [Abstract][Full Text] [Related]
10. Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease.
Park TE; Singh B; Li H; Lee JY; Kang SK; Choi YJ; Cho CS
Biomaterials; 2015 Jan; 38():61-71. PubMed ID: 25457984
[TBL] [Abstract][Full Text] [Related]
11. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
[TBL] [Abstract][Full Text] [Related]
12. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.
Hwang DW; Son S; Jang J; Youn H; Lee S; Lee D; Lee YS; Jeong JM; Kim WJ; Lee DS
Biomaterials; 2011 Jul; 32(21):4968-75. PubMed ID: 21489620
[TBL] [Abstract][Full Text] [Related]
13. A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer's Disease Treatment.
Zhang C; Gu Z; Shen L; Liu X; Lin H
Curr Pharm Biotechnol; 2017; 18(14):1124-1131. PubMed ID: 29484985
[TBL] [Abstract][Full Text] [Related]
14. Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier.
Kim JY; Choi WI; Kim YH; Tae G
Biomaterials; 2013 Jan; 34(4):1170-8. PubMed ID: 23122677
[TBL] [Abstract][Full Text] [Related]
15. Asn194Lys mutation in RVG29 peptide increases GFP transgene delivery by endocytosis to neuroblastoma and astrocyte cells.
Villa-Cedillo SA; Rodríguez-Rocha H; Zavala-Flores LM; Montes-de-Oca-Luna R; García-García A; Loera-Arias MJ; Saucedo-Cárdenas O
J Pharm Pharmacol; 2017 Oct; 69(10):1352-1363. PubMed ID: 28643952
[TBL] [Abstract][Full Text] [Related]
16. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
Varkouhi AK; Verheul RJ; Schiffelers RM; Lammers T; Storm G; Hennink WE
Bioconjug Chem; 2010 Dec; 21(12):2339-46. PubMed ID: 21049986
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
Kim SS; Ye C; Kumar P; Chiu I; Subramanya S; Wu H; Shankar P; Manjunath N
Mol Ther; 2010 May; 18(5):993-1001. PubMed ID: 20216529
[TBL] [Abstract][Full Text] [Related]
20. A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain.
Haroon MM; Dar GH; Jeyalakshmi D; Venkatraman U; Saba K; Rangaraj N; Patel AB; Gopal V
J Control Release; 2016 Apr; 228():120-131. PubMed ID: 26948382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
